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SUMMARY: The production of sophorolipids by Candida bombicola NRRL Y- 17069 grown in a mixture of 
 sunflower oil cake and crude soybean oil as economic substrates with different fermentation techniques was 
studied. The highest yield (49.5 g·100 g−1 substrates) was obtained from solid state fermentation after employ-
ing a new concept for extraction by methanol (E I) followed by ethyl acetate (E II), then partially purified with 
 hexane (E III). The course of time of fermentation was also studied, and E I extracted of the 12th day showed the 
minimum surface tension (45 mN·m−1) at a critical micelle dilution (CMD) of 10% concentration. The produced 
sophorolipids were characterized and confirmed by FTIR and 1H NMR spectroscopy. The anticancer activity 
of the produced compounds was assessed against MCF-7, HepG2, A549, HCT116 cancer cell lines and the 
results revealed that E III and E IV (a mixture of E I & E III) act as promising anticancer agents in HepG2 and 
A549 by inhibiting urokinase and histone deacetylase activities.
KEYWORDS: Anticancer activity; Candida bombicola; Solid state fermentation; Sophorolipids; Soybean oil; Sunflower 
oilcake
RESUMEN: Producción, caracterización y actividad anticancerígena de soforolípidos producidos mediante fer-
mentación en estado sólido con Candida bombicola de tortas de girasol y aceite de soja. Se estudió la producción 
de  soforolípidos por Candida bombicola NRRL Y- 17069 cultiva con diferentes técnicas de fermentación en 
una mezcla de torta de girasol y aceite de soja crudo, como sustratos económicos. El rendimiento más alto 
(49,5 g·100 g−1 de sustrato) se obtuvo por fermentación en estado sólido después de extraer con metanol (IE) 
seguido de acetato de etilo (EII), y de purificación parcial con hexano (EIII). También se estudió el tiempo de 
fermentación, considerando que el extracto IE de 12 días mostró una tensión superficial mínima (45 mN·m−1) 
a una dilución micelar crítica (CMD) de concentración 10 %. Los soforolípidos producidos se caracterizaron y 
se confirmaron mediante espectroscopia FTIR y RMN de 1H. La actividad anticancerígena de los compuestos 
producidos se evaluó en células MCF-7, HepG2, A549, líneas celulares de cáncer de HCT116 y los resultados 
revelaron que EIII y EIV (una mezcla de EI y EIII) actúan como prometedores agentes anticancerígenos en 
HepG2 y A549 inhibiendo las actividades de uroquinasa e histona desacetilasa.
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Soforolípidos; Torta de girasol
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1. INTRODUCTION
Biosurfactants are surface-active compounds 
produced by microorganisms. Most microbial sur-
factants are complex molecules, comprising of 
different structures which include lipopeptides, 
glycolipids, polysaccharide-protein complex, fatty 
acids and phospholipids (Nitschke and Pastore, 
2006). Sophorolipids (SLs), a kind of extracellular 
biosurfactants, which are produced by yeasts, have 
been known for a long time, and each of them is 
comprised of one sophorose molecule, a hydrophilic 
part, linked to one hydroxyl fatty acid, a lipophilic 
part by one or two crosslines (Cavalero and Cooper, 
2003).
A select number of yeast species, such as Candida 
apicola (Gorin et al., 1961), Candida bogoriensis 
(Tulloch et al., 1968), Wickerhamiella domercqiae 
(Chen et al. 2006a), Pichia anomala (Thaniyavarn 
et al., 2008), Candida guilliermondii (Sitohy et al., 
2010), and Candida bombicola (Spencer et al. 1970, 
Daverey and Pakshirajan, 2009, Parekh et al., 2012) 
etc., were reported to produce extracellular bio- 
surfactant as SLs.
It is well known that the cost of raw materials 
generally contributes up to 75% of the selling price 
of bio-products. Hence, in order to compete with a 
cheaper chemical surfactant, it is important to use 
a suitable low-cost fermentation media for the pro-
duction of SLs. In other words, biosurfactants can 
replace synthetic ones, which may result in main-
taining the cost of the raw materials in its production 
process at a minimum (Daverey and Pakshirajan, 
2009). 
Several renewable substrates from various sources, 
particularly from well-known industrial wastes have 
been intensively studied for microorganism cultiva-
tion and biosurfactant production on a laboratory 
scale (Daniel et al., 1998; Solaiman et al., 2004; 
Felse et al., 2007; Thavasi et al., 2008; Sitohy et al., 
2010; Parekh et al., 2012).
Worldwide production of oils and fats is about 
2.5–3 million tons, 75% of which is derived from 
plants (Haba et al., 2000), which generates great 
quantities of waste called oil cakes. Annual growth 
in oil cake production was projected to average 
2.3% over the decade to 2010 (Ramachandran et al., 
2007). Their applications in the field of fermenta-
tion technology have resulted in the production of 
bulk-chemicals and value-added products. (Pandey 
et al., 1999; Vandenberghe et al., 2000; Nampoothiri 
et al., 2002; Soccol et al., 2005; Roopesh et al., 2006; 
Rashad et al., 2012).
In recent years, SLs have attracted much atten-
tion for their applications due to their good surface 
activity, biodegradability, biocompatibility, low tox-
icity, production process under mild conditions, and 
production from renewable materials (Lee et  al., 
2008). Also, SLs have attracted more attention since 
they were found to have good anti-microbial, anti-
inflammatory, and even anti-HIV activities, which 
will broaden their applications in the pharma-
ceutical sector (Shah et al., 2005; Yoo et al., 2005; 
Napolitano 2006). Natural SL molecules and their 
specific derivatives have recently been reported to 
have anticancer effects against liver, leukemia, pan-
creatic, and esophageal cancer cells (Chen et al., 
2006b; Fu et al., 2008, Shao et al., 2012). However, 
little is known about the pharmacological roles of 
SLs as anticancer drugs. Although there have been 
great advances in the detection and treatment of 
cancer, it remains one of the greatest medical chal-
lenges. Therefore, the need for better treatments has 
stimulated research to develop new efficient chemo-
therapeutic agents for the management of cancer. 
Urokinase plasminogen activator (uPA) is a serine 
protease that functions in the conversion of the 
circulating plasminogen to the active serine prote-
ase plasmin. uPA is involved in many physiological 
functions and it has been implicated in cancer inva-
sion and metastatization (Bdeir et al., 2003; Duffy 
and Duggan, 2004). In addition, Histone deacety-
lases (HDACs) are a class of enzymes which play an 
important role in gene expression (Hu et al., 2000). 
Because it has been reported that its inhibition 
brought about cell-cycle arrest and induced differen-
tiation (Komatsu and Hayashi, 1998), HDAC is con-
sidered a target for new types of pharmaceuticals. A 
possible application of HDAC inhibitors would be 
the treatment of cancer (Komatsu et al., 2001).
Therefore, the objective of the present work was 
to investigate the production and properties of SLs 
from Candida bombicola cultivated in a mixture of 
sunflower oil cake and crude soybean oil as alterna-
tive unconventional substrates and also, to explore 
a possible application of the produced SLs in the 
pharmaceutical field as anticancer agents by study-
ing their in vitro cytotoxicity and anti-proliferative 
activity on four human cell lines.
2. MATERIALS AND METHODS
2.1. Yeast strain
Candida bombicola NRRL Y-17069 was obtained 
from the Agricultural Research Service, Peoria, 
Illinois, USA. The culture was kept in a stock slant 
medium (Wickerman, 1951).
2.2. Substrates
Sunflower seeds (Giza 1) were obtained from the 
local market (Cairo, Egypt). The seeds were pressed 
with laboratory-type Carver hydraulic press under 
10.000 Ib in −2 pressure for 1 h at room temperature 
according to Üstun et al. (1990), then the sunflower 
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oil cake residue was collected, frozen and kept at 
−4 °C until analysis. Crude soybean oil was obtained 
from the Food Technology Research Institute, 
Soy Processing Center, Agriculture Research Center, 
Giza, Egypt. All chemicals and reagents used were 
of analytical grade.
2.3. Inoculum preparation
The inoculum was prepared by transferring a 
loopful of a stock culture (7 days old) of C. bombic-
ola to a 50 ml sterile inoculum medium (Wickerman, 
1951), which was then incubated at 30 °C, 180 rpm 
for 24h.
2.4. Cultivation conditions
2.4.1. Submerged fermentation (medium I)
An aliquot of 1 mL of the inoculum with cell 
density (1×108 cells mL−1) was transferred to an 
Erlenmeyer flask (250 ml) containing 50 mL of the 
medium (modified from kim et al., 1999) consisting 
of (g·L−1) sunflower oil cake waste, 50; soybean oil, 
50; NH4NO3 1.0; K2HPO4, 2.55; NaH2PO4, 0.15; 
MgSO4.7H2O, 0.5; CaCl2.2H2O, 0.1; MnSO4.H2O, 
0.02; peptone, 1.0. The final pH was 7.8 and the 
mixture was incubated for 96 h, at 180 rpm in a con-
trolled incubator shaker (New Brunswick Scientific, 
USA) at 30 °C.
2.4.2. Submerged fermentation (medium II)
This was done as described above for medium I 
but without the addition of soybean oil.
2.4.3. Solid state fermentation (medium III)
The solid state fermentation (SSF) medium was 
prepared according to the method of Ohno et al. 
(1995) with some modifications as follows: 1 mL of 
the overnight culture was mixed for seeding thor-
oughly with 5 g of sunflower oil cake waste, 5 g 
of soybean oil and 4 mL of previously mentioned 
nutrients (mediumI). Then, the cultures were grown 
for 96 h in a static incubator at 30 °C. 
2.5. Extraction of Sophorolipids
2.5.1.  Extraction from submerged medium
(media I and II)
The crude SL was isolated from the submerged 
medium according to kim et al. (1999). The fer-
mented product was centrifuged at 15000 rpm for 15 
min. and the supernatant was then twice extracted 
using 2 volumes of ethyl acetate. The extracts were 
collected and treated with anhydrous sodium sulfate, 
then the ethyl acetate was evaporated by rotary 
evaporator and the residue was collected.
2.5.2. Extraction from solid medium
a. Methanol Extraction 
As for SSF, the crude SL was isolated according to 
Ohno et al. (1995) by adding 45ml of methanol to one 
volume of the solid media and the mixture was shaken 
at 92 strokes min−1 for 60 min with a reciprocal shaker 
(New Brunswick Scientific, USA). The crude extract 
was then filtered through a 0.20 μm membrane filter 
(GELMAN sciences, USA), to obtain the methanol 
extract (E I) (Roongswang et al., 2002). 
b. Re-extraction by ethyl acetate
A modification was made by re-extracting the fer-
mented substrates (after isolation of EI) with 45mL 
of ethyl acetate and shaking at 92 strokes min−1 for 
60 min with a reciprocal shaker, filtered through a 
0.20 μm membrane filter to obtain the second ethyl 
acetate extract (E II). The crude SL was further 
purified according to Hu and Ju (2001) as follows: 
the previously obtained ethyl acetate extract (E II) 
was vacuum-dried at 40 °C to remove the solvent. 
The residue was twice washed with 10ml hexane to 
remove any remaining soybean oil, and probably 
some hydrophobic substances such as fatty acids and 
alcohols formed in the fermentation. Partially puri-
fied SL extract (E III) was thus obtained after vapor-
izing the residual hexane at 40 °C under vacuum.
2.6. Characterization of Sophorolipids
Surface tension and critical micelle dilution 
(CMD) were determined with Du-Nouy tensiometer 
(Kruss type 8451). CMD is defined as the reciprocal 
of the SL dilution at which a sharp increase in sur-
face tension is observed. To determine the CMD, dif-
ferent serial dilutions were done for the SL extracts 
(EI, EII, and EIII) obtained from C. bombicola 
(McInerney et al., 2004).
2.7. Fourier transform infrared spectroscopy (FTIR)
The infrared (IR) spectrum (from 400 to 4000 
wave numbers, cm−1) of SL extracts were recorded 
using a KBr pellet in Nicolet Impact 6100 FTIR 
spectrophotometer JASCO, USA.
2.8. NMR spectra analysis
The NMR spectra were recorded on a Varian 
Mercury VX-300 NMR spectrometer. 1H spectra 
were run at 300 MHz in deuterated chloroform 
(CDCl3). Chemical shifts are quoted in δ and were 
related to those of the solvents.
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2.9. Cell lines and culturing
Anticancer activity screening for the tested com-
pounds with 4 different human tumor cell lines 
including breast adenocarcinoma MCF-7; hepato-
cellular carcinoma HepG2, lung cancer A549 and 
colon cancer HCT116 which were obtained from the 
American Type Culture Collection (Rockville, MD, 
USA). The tumor cells were kept in Dulbecco’s mod-
ified Eagle’s medium (DMEM) supplemented with 
10% heat inactivated fetal calf  serum (GIBCO), peni-
cillin (100 U·mL−1) and streptomycin (100 μg·mL−1) 
at 37 °C in a humidified atmosphere containing 
5% CO2. Cells at a concentration of 0.50×10
6 were 
grown in a 25 cm2 flask in 5 mL of a complete cul-
ture medium.
2.10. In vitro Anti-proliferative Assay
The anti-proliferative activity was measured 
in vitro using the 3-(4,5-dimethyl-2-thiazolyl)-2, 
5-diphenyl-2H-tetrazolium bromide (MTT) assay 
according to the previously reported standard 
procedure (Mosmann 1983). The absorbance was 
measured with a microplate reader (AsysHitech, 
Austria) at 570 nm. The relationship between sur-
viving fraction and compound concentration was 
plotted to get the survival curve for each cell line 
after the specified time. The concentration required 
for 50% inhibition of cell viability (IC50) was 
calculated.
2.11.  Determination of the level of uPA protein 
expression 
The level of urokinase (uPA) protein expres-
sion was determined using AssayMax human uPA 
ELISA kit (Assaypro, USA) according to manu-
facturer’s instructions. The prepared compounds as 
well as a standard drug, doxorubicin were incubated 
for 48 h with, HepG2 and A549 cells at a concentra-
tion of 1/10 of the IC50 values of each compound.
2.12.  Determination of Histone deacetylase
(HDAC) activity
Histone deacetylase inhibitors represent a prom-
ising new class of compounds for the treatment of 
cancer (Walkinshaw and Yang, 2008). The activity 
of HDAC in the lysate of hepatic HepG2 and lung 
A549 cancer cells treated with the prepared com-
pounds was measured using a colorimetric assay kit 
(BioVision, Mountain View, kit no. K331-100).
2.13. Statistical analysis
The results are reported as Mean±Standard error 
(S.E.) for experiments repeated at least four times. 
Statistical differences were analyzed according to 
the one way ANOVA test followed by the student’s t 
test wherein the differences were considered to be 
significant at p<0.05.
3. RESULTS AND DISCUSSIONS
3.1. Sophorolipid production 
Utilization of  a local waste for a maximum 
production of  crude biosurfactant with low cost 
production materials and processing was the 
main purpose of  this work. Different fermenta-
tion techniques were used in this study. By using 
a submerged medium (medium I), the crude SL 
obtained reached the level of  20.6 g·100 g−1 sub-
strate by extraction with ethyl acetate from the 
substrates (sunflower oil cake plus soybean oil) on 
the fourth day of  fermentation (Figure 1). While a 
non-significant amount of  SL was produced from 
the same medium without soybean oil (medium II). 
The yield obtained from the medium I (41.2 g·L−1) 
was higher than that of  Davery and Pakshirajan 
(2010), who found that the maximum yield of 
C.  bombicola SL ranged from 23.3 to 33.3 g·L−1 
using mixed hydrophilic substrates. Also, it was 
higher than that obtained by Parekh et al. (2012) 
(5.8 g·100 g−1 substrate) using C.  Starmerella 
grown in submerged media containing vari-
ous lipids and fatty acids obtained from mango 
kernel. On the other hand, the present yield was 
slightly lower than that produced by Li et al. 2013 
(47 g·L−1) and Sudha et al., 2010 (49.8 g·L−1) using 
Wickerhamiella domercqiae var. and C. tropicalis 
respectively. By using SSF for the same substrates, 
which consists of  sunflower oil cake plus soybean 
oil (medium III), different extraction methods were 
examined in one step extraction. Using methanol 
as extraction solvent, the extract (E I) gave a yield 
of  SL 17 g·100 g−1 substrate, while the extraction 
by ethyl acetate gave a yield of  22 g·100 g−1 sub-
strate. However, using a mixture of  methanol and 
ethyl acetate at a ratio of  1:1 (in one step extrac-
tion), the yield was 15 g·100 g−1 substrate.
On the other hand, employing a new concept 
for the production process by re-extraction of the 
remaining fermented media (after isolation of EI) 
with ethyl acetate (E II) resulted in a higher addi-
tional amount of the produced SL (32.5 g·100 g−1) as 
shown in Figure 1. This new method of re-extraction 
produced a higher yield of SL than the traditional 
extraction method for the solid medium using meth-
anol alone, whereas the two extracts (E I and E II) 
produced a level of 49.5 g·100 g−1 for the same sub-
strates on the fourth day of fermentation. 
Parekh et al. (2012) found that the SL obtained 
from C. Starmerella with SSF of mango kernel was 
17.48 g·100 g−1 substrate after extraction by ethyl 
acetate, which was lower than our results for ethyl 
acetate extraction alone (22 g·100 g−1 substrate).
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On  the other hand, the total yields obtained in 
this study from methanol extract EI (17 g·100 g−1 sub-
strate) and ethyl acetate re-extract EII (32.5 g·100 g−1 
substrate) were significantly higher (49.5 g·100 g−1 
substrate).
The highest yield obtained from medium III 
using our modified re-extraction method was con-
firmed to be the most suitable extraction method 
used. From all the above results, it can be concluded 
that the SSF technique is a suitable technique for 
further studies with the two steps of extraction. 
The course of time of SL production during 
the SSF (medium III) using the modified extrac-
tion method investigated in this study is presented 
in Figure 2. It can be observed that the methanol 
extract (E I) productivity was directly proportional 
with incubation time, whereas the higher yield of SL 
was obtained on the 16th and 12th days, giving 28.75 
and 28.11 g·100 g−1 substrate, respectively; while, 
lower yields were achieved on the 4th and 8th days of 
incubation (17 and 20.52 g·100 g−1 substrate, respec-
tively). However, the ethyl acetate re-extract (E II) 
FIGURE 1. The yield of sophorolipids from different fermentation techniques and different solvents on the 4th day of fermentation
(data were expressed as mean±S.E. of 4 experiments).
FIGURE 2. The course of time of sophorolipid production during solid state fermentation (medium III) using the modified 
extraction method investigated (data were expressed as mean±S.E. of 4 experiments).
6 • M.M. Rashad, M.U. Nooman, M.M. Ali, A.S. Al-kashef and A.E. Mahmoud
Grasas Aceites 65 (2), April–June 2014, e017. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.098413
productivity was inversely proportional with incu-
bation time, where the higher SL yield was obtained 
on the 4th and 8th days (32.5 and 22.13 g·100 g−1 
substrate, respectively); subsequently the lower yield 
was produced on the16th and 12th days of fermenta-
tion (10.5 and 12.8 g·100 g−1 substrate, respectively). 
The highest yield obtained from both extracts over 
the course of fermentation time was 49.5 g·100 g−1 
substrate on the 4th day, while the lowest was 39.25 
g·100 g−1 substrate on the 16th day of incubation.
3.2.  Identifi cation and characterization of 
sophorolipids 
One of the important characterization proper-
ties of a potent surfactant is its ability to lower 
the surface tension in aqueous solutions. CMD is 
an indirect indication of surfactant concentration 
(Makkar and Cameotra, 1997). So, the surface ten-
sion (S.T.) and critical micelle dilution (CMD) were 
determined to evaluate the surface activity of the 
produced SL resulting from both solvents (E I and 
E II) during the fermentation period. It was found 
that the SL extracted with methanol (E I) on the 
12th day showed the highest efficiency in reducing 
the surface tension of water from 70 to 45 mN·m−1 
when the sample was diluted to 0.1X (10% concen-
tration) which corresponds to its CMD, followed by 
the ethyl acetate extract (E II) on the same day which 
gave 48 mN·m−1 at the same dilution (0.1X) of 10% 
concentration CMD. This ethyl acetate extract (E II) 
was partially purified by hexane to produce the E III 
extract, which was found to have a non-significant 
effect on reducing the surface tension (47 mN·m−1) 
compared to the E II extract at the same CMD 
(Figure 3). However, the surface tension of the other 
SL extracts using both solvents during the fermenta-
tion period (4–16 days) ranged from 51–56 mN·m−1.
In light of the above results, more studies will be 
done on the compounds (E I, E II and E III) on the 
12th day of fermentation. These results of S.T. for 
E I & E II nearly coincide with those reported by 
Kim et al. (2005), in that the S.T. of C. bombic ola SL 
was 48 mN·m−1 when grown in a medium contain-
ing glucose and dark soybean oil as carbon sources. 
However, they were lower than those stated by 
Amaral et al. (2006), who found that the biosurfac-
tant from Yarrowia lipolytica has the ability to reduce 
S.T. by up to 50 mN·m−1
On the other hand, the prepared SL exhibited a 
higher minimum S.T. than that produced from many 
candida species and ranged from 32–39 mN·m−1 
(Sobrinho et al., 2008; Daverey and Pakshirajan 
2009, 2010; Chandran and Das 2011).
3.3. FT-IR analysis 
The FT-IR spectra of the prepared SL com-
pounds (E I, E II and E III) showed mostly identi-
cal absorption bands (Figure 4). The FT-IR spectra 
for all extracts revealed broad bands at 3385–3424 
cm−1 which correspond to the O-H stretch, while 
asymmetrical stretching (vas CH2) and symmetrical 
stretching (vs CH2) of methylene occurs at 2926 cm
−1 
and 2855 cm−1 respectively. Absorption bands at 
(1742–1745 cm−1) contribute to C=O stretching from 
lactone ester or acids. The C=O absorption band 
from acetyl esters was observed at 1238–1240 cm−1 
in all structures, while the bands at 1460 cm−1 cor-
responded to the C-O-H in the plane binding of car-
boxylic acid (-COOH) in the structure of the three 
products. The stretch of C-O band of C (-O)-O-C 
in lactones exists in all products at 1164–1170 cm−1, 
also the C-O stretch from C-O-H groups of sugar 
(sophorose moiety) is observed at 1080–1098 cm−1; 
finally the IR spectra revealed the absorption band 
FIGURE 3. The surface tension and critical micelle dilution (CMD) of the produced sophorolipid extracted by methanol (E I), 
ethyl acetate (E II) and purified by hexane to form ethyl acetate extract (E III). The critical micelle dilutions (CMD ) are marked in 
circles (data were expressed as mean±S.E. of 4 experiments).
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for C=C at 719–723 cm−1 in all the studied struc-
tures. All these structural details of the products 
were found similar to those reported by Yongmei 
and Lu-Kwang (2001); Daverey and Pakshiragan 
(2009) and Bajaj et al. (2012), which confirmed that 
these products are SL compounds.
3.4. 1 H NMR analysis
The structure of the produced SL compounds (E I, 
E II and E III) was elucidated using 1H NMR analy-
sis. The spectra of the three extracts were assigned 
to a typical glycolipid-type structure. In all com-
pounds, the signals of the vinyl group (–CH=CH–) 
were at 5.32≈5.39 ppm, while the signals at 2.08 ppm 
were denoting the presence of–CH3 group. Multiple 
peaks from 1.23 to 1.31 ppm put the accent on the 
existence of fatty acid chain moiety in all structures. 
The presence of the–CO-CH3 group in all structures 
was confirmed by the signals at 2.06 ppm in the spec-
tra; on the other hand, the protons of two glucose 
were resonated at 3.4≈4.3 ppm in the Hexane frac-
tion (E III). The signals obtained were similar to the 
one in the 1H NMR spectrum of the SL compounds 
reported by other researchers (Wei et al., 2005; 
Chen et al., 2006a; Gao et  al., 2007; Daverey and 
Pakshiragan 2009 and Bajaj et al., 2012).
According to the results of the FT-IR and 1H 
NMR analyses, all these structural features further 
confirmed the SL group of compounds (acidic and 
lactone ring form) in the produced biosurfactants.
3.5. In vitro anti-proliferative activity
The anti-proliferative activity of the produced 
crude and partially purified SLs (E l, E II and E III) 
and a mixture of E I and E III (E IV) was evaluated 
against breast adenocarcinoma MCF-7; human 
hepatocellular carcinoma HepG2, human lung can-
cer A549 and human colon cancer HCT116 cell 
lines using an MTT colorimetric assay, in compari-
son with doxorubicin as reference drug. The results 
revealed that all compounds did not exert any activ-
ity against human breast cancer MCF-7 or colon 
cancer HCT116 cell lines.
The anti-proliferative activities are expressed by 
median growth inhibitory concentration (IC50) and 
provided in Table 1. From the results it is evident 
that the tested SLs compounds displayed potent 
growth inhibitory activity against only two tested 
cell lines (HepG2 and A549). 
The IC50 of compounds E l, E II, E III and E IV 
for the HepG2 cell line was 47.00±4.20, 36.00±3.50, 
23.70±2.63 and 19.00±1.80 μg·mL−1 respectively. It is 
clear that, while the IC50 of E III (23.70±2.63 μg·mL
−1) 
is close to the value of the reference drug, doxo-
rubicin (20.10±2.00 μg·mL−1), the mixture of the 
2 extracts (E IV) was more potent (19.00±1.80 
μg·mL−1) than the doxorubicin. Similarly, the IC50 of 
SL compounds E I, E II, E III and E IV for the A549 
cell line was 46.60±4.30,  41.20±4.60, 29.00±2.80 
TABLE 1. Cytotoxicity (IC50, μg·mL
–1) activity of the 
produced sophorolipid compounds (E I, E II, E III and 
E IV) against four human malignant cell lines
as measured with the MTT assay method
Compound
Cell line
HepG2 MCF-7 A549 HCT116
Doxorubicin 20.10±2.00 24.00±2.50 25.50±2.70 19.25±2.00
E I 47.00±4.20 NA 46.60±4.30 NA
E II 36.00±3.50 NA 41.20±4.60 NA
E III 23.70±2.63 NA 29.00±2.80 NA
E IV 19.00±1.80 NA 25.77±2.20 NA
Data are expressed as means±S.E. of four separate experiments.
NA: no activity.
FIGURE 4. FTIR spectra of the produced sophorolipid 
compounds E I, E II and E III.
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and 25.77±2.20 μg·mL−1 respectively. It is clear that 
the mixture (E IV) was more potent (25.77±2.20 
μg·mL−1) than doxorubicin (25.50±2.70 μg·mL−1).
3.6. The level of uPA protein expression 
To identify the mechanism of action responsible 
for the cytotoxicity of the prepared SL compounds, 
the level of urokinase (uPA) protein expressed in 
the two cell lines (HepG2 and A549) were estimated 
quantitatively. 
In the case of the hepatic cancer cell line HepG2 
and lung cancer cell line A549, the SL compounds E 
I and E II have no effect on the expression of uPA, 
only 4 and 3% inhibition were obtained in HepG2, 
while 2% and 2% inhibition were obtained in A549 
cells. On the other hand, the level of uPA expression 
decreased in SL compounds E III and E IV by the 
following percent, E III (65, 55%) and E IV (75, 
63%) in HepG2 and A549, respectively. From the 
results, the sophorolipid compound E IV exhib-
ited a good anticancer activity in HepG2 and A549 
similar to doxorubicin (92% and 86%, respectively) 
(Figure 5). In both HepG2 and A549 the inhibition 
of uPA activity of the tested SLs compounds was in 
accordance with the cytotoxicity activity.
3.7. Histone deacetylase (HDAC) activity
Histone deacetylase (HDAC) inhibitors are a new 
class of targeted anticancer agents which are potent 
inducers of growth arrest, differentiation, and/or 
apoptotic cell death of transformed cells in vitro and 
in vivo (Bi and Jiang, 2006). Thereby, we examined 
FIGURE 5. The percent of uPA inhibition of the produced sophorolipid compounds (E I, E II, E III and E IV) comparing to 
doxorubicin in HepG2 and A549 cell lines (data were expressed as mean±S.E. of 4 experiments).
FIGURE 6. The effect of the prepared sophorolipid compounds (E I, E II, E III and E IV) on HDAC activity in HepG2 and A549 
cell lines after treatment with the prepared compounds and cells with Trichostatin, as a known HDAC inhibitor. The data was
compared with the HDAC activity of the control cancer cells (data were expressed as mean±S.E. of 4 experiments).
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the effect of the prepared SL compounds as histone 
deacetylase inhibitors in an attempt to use them in 
tumor treatment.
In this work the activity of HDAC in the lysate 
of hepatic HepG2 and lung A549 cancer cells 
treated with the prepared SL compounds as well as 
Trichostatin, as a known inhibitor, was measured 
and the data were calculated as percentage of inhi-
bition as compared to the control, untreated cancer 
cells. While the treatment of hepatic HepG2 and 
lung A549 cancer cells with Trichostatin resulted in 
60% and 48% inhibition, respectively, as compared 
with the control untreated cancer cells, the treatment 
with compounds E l, E II, E III and E IV resulted 
in 6, 8, 38 and 47%, respectively in hepatic HepG2 
cells. Similarly, the treatment of lung A549 cells with 
all the prepared SL compounds (E I-E IV) resulted 
in the inhibition of the activity of HDAC by 3, 5, 32 
and 39%, respectively (Figure 6).
Taken together, these findings suggest that 
there are correlations between the cytotoxicity of 
the tested SL compounds and inhibition of  the 
urokinase and Histone deacetylase activities. The 
tested compounds exert anti-carcinogenic activ-
ity in hepatic HepG2 and lung A549 cancer cell 
lines by lowering the activity of  these enzymes 
which may reduce the cell proliferation and result 
in significant growth inhibition. The potent anti-
cancer effect of  the compound E IV needs further 
investigation. 
Chen et al. (2006b) studied the cytotoxic effects 
of the SL produced by the yeast Wickerhamiella 
domercqiae on cancer cells of liver, lung and leu-
kemia (H7402, A549, HL60 andK562). The results 
showed a dose-dependent inhibition ratio on cell 
viability according to the drug concentration ≤62.5 
µg·mL−1, which suggested that the SL produced by 
W. domercqiae have anticancer activity.
Fu et al. (2008) have demonstrated that acidic 
SL had stronger cytotoxicity (35.5% cytotoxicity at 
100 mg mL concentration) than lactonic SL (26.2% 
cytotoxicity at 100 mg·mL−1 concentration) against 
pancreatic cancer cells and he reported that these 
different results are probably attributed to the inhi-
bition mechanism of SL on pancreatic cancer cells, 
which are different from other cancer cells. Also, 
Shao et al. (2012) investigated the bioactivity of SLs 
with different structures against human esophageal 
cancer cells, and the results revealed that the SLs 
with different unsaturation degrees of hydroxyl fatty 
acids had different cytotoxic effects on esophageal 
cancer cells.
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